DISCOUNT ZERTIFIKAT - AMGEN | Market Closed - Börse Stuttgart 20:02:44 28/06/2024 BST | ||
| 212.1 EUR | -0.02% |
|
| Current month | +1.66% | ||
| 1 month | +2.10% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 212.1 | -0.02% |
| 27/06/24 | 212.1 | -0.48% |
| 26/06/24 | 213.1 | +0.32% |
| 25/06/24 | 212.4 | +0.21% |
| 24/06/24 | 212 | -0.30% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 08:02 pm
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680N |
| ISIN | DE000ME680N3 |
| Date issued | 02/01/2024 |
| Cap | 230 $ |
| Last trading day | 20/09/2024 |
| Maturity | 20/09/2024 (83 Days) |
| Parity | 1 : 1 |
| Emission price | 200 € |
| Emission volume | N/A |
| Payment day | 27/09/2024 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 27.28 % |
|---|---|
| Sideways yield | 1.241 % |
| Sideways yield pa | 5.393 % |
| Outperformance point | 316.3 $ |
| Break even | 227.18 € |
| Highest since issue | 213.1 € |
| Lowest since issue | 196.9 € |
| Spread | 0.06 € |
| Spread % | 0.03% |
| Distance Cap | 82.45 $ |
| Distance Cap % | +26.39% |
| Max. earning | 2.632 |
| Max. earning % | 1.241 % |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Certificates
- Certificat
